Ocrevus and PPMS: Where to from here? MStranslate September 10, 2018 Ocrelizumab, Opinion, Treatments The following is an opinion piece written by MStranslate co-founder, Brett Drummond. Let’s rewind to last March last year…there is worldwide...
Multiple Sclerosis Research 2017: Predictions Revisited MStranslate December 20, 2017 Epstein-Barr virus, Opinion, Research On January 10, 2017, I wrote an opinion piece about what I thought would be the biggest developments in multiple sclerosis research in 2017. Now,...
US FDA Approves Ocrelizumab (Ocrevus) MStranslate March 30, 2017 Ocrelizumab, Treatments Ocrelizumab (Ocrevus) has been granted US FDA approval for the treatment of both replacing-remitting MS (RRMS) and primary progressive MS (PPMS)....
Ocrelizumab in Primary Progressive MS MStranslate January 13, 2017 Ocrelizumab, Research, Treatments Research Summary: Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis There has been a lot of hype over ocrelizumab as the next...
